← Evidence map

ArticleInternational journal of health policy and management2016

Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Brent L RollinsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016

this papercites it

Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". | OpenQuestion